These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 9721853
1. Beta-catenin mutation in carcinoma of the uterine endometrium. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hirohashi S. Cancer Res; 1998 Aug 15; 58(16):3526-8. PubMed ID: 9721853 [Abstract] [Full Text] [Related]
2. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG, Matías-Guiu X, Esteller M, Palacios J. Oncogene; 2002 Nov 14; 21(52):7981-90. PubMed ID: 12439748 [Abstract] [Full Text] [Related]
3. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Int J Oncol; 2002 May 14; 20(5):905-11. PubMed ID: 11956582 [Abstract] [Full Text] [Related]
4. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M. Cancer Res; 1999 Jul 15; 59(14):3346-51. PubMed ID: 10416591 [Abstract] [Full Text] [Related]
5. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. Nat Genet; 2000 Mar 15; 24(3):245-50. PubMed ID: 10700176 [Abstract] [Full Text] [Related]
6. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Tanyi J, Páy A, Rigó J, Nagy B, Papp Z. Orv Hetil; 2000 May 21; 141(21):1115-9. PubMed ID: 10876313 [Abstract] [Full Text] [Related]
7. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Saegusa M, Hashimura M, Yoshida T, Okayasu I. Br J Cancer; 2001 Jan 21; 84(2):209-17. PubMed ID: 11161379 [Abstract] [Full Text] [Related]
8. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. Saegusa M, Okayasu I. J Pathol; 2001 May 21; 194(1):59-67. PubMed ID: 11329142 [Abstract] [Full Text] [Related]
9. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Shiina H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M, Deguchi M, Ribeiro-Filho L, Dahiya R. Cancer Res; 2001 Oct 01; 61(19):7101-9. PubMed ID: 11585741 [Abstract] [Full Text] [Related]
10. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Choi YW, Heath EI, Heitmiller R, Forastiere AA, Wu TT. Mod Pathol; 2000 Oct 01; 13(10):1055-9. PubMed ID: 11048797 [Abstract] [Full Text] [Related]
11. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426 [Abstract] [Full Text] [Related]
12. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y. Oncol Res; 1998 Jul 18; 10(11-12):591-4. PubMed ID: 10367940 [Abstract] [Full Text] [Related]
13. Beta-catenin mutations in biliary tract cancers: a population-based study in China. Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, Fraumeni JF, Hsing AW. Cancer Res; 2001 Apr 15; 61(8):3406-9. PubMed ID: 11309300 [Abstract] [Full Text] [Related]
14. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ. Mod Pathol; 2002 Apr 15; 15(4):454-61. PubMed ID: 11950921 [Abstract] [Full Text] [Related]
15. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. Xu B, Yoshimoto K, Miyauchi A, Kuma S, Mizusawa N, Hirokawa M, Sano T. J Pathol; 2003 Jan 15; 199(1):58-67. PubMed ID: 12474227 [Abstract] [Full Text] [Related]
16. beta-Catenin alteration in cancer of the ampulla of Vater. Kawakami M, Kimura Y, Furuhata T, Zenbutsu H, Yanai Y, Mukaiya M, Satoh Y, Murata S, Hirata K. J Exp Clin Cancer Res; 2002 Mar 15; 21(1):23-7. PubMed ID: 12071524 [Abstract] [Full Text] [Related]
17. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Cancer Res; 1999 Apr 15; 59(8):1811-5. PubMed ID: 10213482 [Abstract] [Full Text] [Related]
18. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. Cancer Res; 1998 Jan 01; 58(1):42-6. PubMed ID: 9426055 [Abstract] [Full Text] [Related]
19. Beta-catenin mutations in sporadic fundic gland polyps. Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, Hirohashi S. Virchows Arch; 2002 Apr 01; 440(4):381-6. PubMed ID: 11956818 [Abstract] [Full Text] [Related]
20. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. Oncogene; 2000 Jan 27; 19(4):498-504. PubMed ID: 10698519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]